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Cargo selectionOuter membrane vesicles (OMVs) are constitutively produced by all Gram-negative bacteria. OMVs form when
buds from the outer membrane (OM) of cells encapsulate periplasmic material and pinch off from the OM to
form spheroid particles approximately 10 to 300 nm in diameter. OMVs accomplish a diversity of functional roles
yet the OMV's utility is ultimately determined by its unique composition. Inclusion into OMVsmay impart a variety
of beneﬁts to the protein cargo, including: protection from proteolytic degradation, enhancement of long-distance
delivery, speciﬁcity in host-cell targeting, modulation of the immune response, coordinated secretion with other
bacterial effectors, and/or exposure to a unique function-promoting environment. Many enriched OMV-
associated components are virulence factors, aiding in host cell destruction, immune system evasion, host cell inva-
sion, or antibiotic resistance. Although the mechanistic details of how proteins become enriched as OMV cargo re-
main elusive, recent data onOMbiogenesis and relationships between LPS structure andOMV-cargo inclusion rates
shed light on potential models for OM organization and consequent OMV budding. In this review, mechanisms
based on pre-existing OMmicrodomains are proposed to explain how cargo may experience differing levels of en-
richment in OMVs and degrees of association with OMVs during extracellular export. This article is part of a Special
Issue entitled: Protein trafﬁcking and secretion in bacteria. Guest Editors: Anastassios Economou and Ross Dalbey.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
All Gram-negative bacteria studied to date release outer membrane
vesicles (OMVs) in every stage of growth and in a range of different
environmental conditions [1–4]. Originating from the cell envelope,
OMVs are spheroid particles, approximately 10 to 300 nm in diameter,
composed of a membrane bilayer enclosing a proteinaceous lumen [4].
Components of OMVs include lipopolysaccharide (LPS), phospholipids,
DNA, RNA, as well as proteins localized to the cytoplasm, inner mem-
brane (IM), periplasm, and outer membrane (OM).
Formationofvesicles isaubiquitousprocess,occurringin liquidculture,
solidculture, andinbioﬁlms [5].Notably,OMVscontainnewlysynthesized
proteinsandformintheabsenceofcelldeathorbacterial lysis [6–9].OMVs
areobserved in theprocessofbuddingandpinchingoff frommultiple sites
on the bacterial OMby electronmicroscopy [1,3,7,10–12].
Much research has delved into the complex cellular regulation of
OMVproduction. The regulation of OMVproduction seems to be depen-
dent upon a number of factors including environmental conditions,
pathogenicity, and the overall cellular metabolic state. Neither the
rates of OMV production between various bacterial species nor the pro-
duction rates for a single species between varying environmental condi-
tions are uniform.rafﬁcking and secretion in bac-
ey.
uke University Medical Center,
919 684 8885.
ights reserved.Quantitative analyses have demonstrated that Escherichia coli pack-
ages an estimated 0.2–0.5% of OM and periplasmic proteins into OMVs
[6,13,14]. Approximately 1% of OMmaterial is incorporated into vesicles
for typical lab strains of E. coli and Pseudomonas aeruginosa, whereas
log-phase cultures of Neisseria meningitidis incorporate 8–12% of total
protein and endotoxin into vesicles [15–18]. The utilization of OMVs
for protein export is suggested by experimental evidence of enrichment
and exclusion ofmembranous and soluble cargo in vesicles as compared
with their respective concentrations inwhole bacteria, the periplasm, or
the OM. As formation and release of OMVs results in the export of more
cellular material than other methods of secretion, vesicle production is
likely highly regulated and optimized for maximum functionality.
2. The OMV pathway in comparison with other methods of
protein export
Protein export via OMVs offers several distinct advantages over
other secretory mechanisms. Firstly, the protein cargo exits the cell in a
medium inaccessible to extracellular degradative enzymes. Proteins lo-
cated in the vesicle lumen are insensitive to protease treatment [19,20].
Accordingly, vesicles are thought to be capable of long-distance transport.
OMV antigens disperse to sites far from initial colonization, such as the
urine, blood, and a number of organs of Borrelia burgdorferi-infected
mice, dogs, and humans [21].
Protein cargo bereft of a mechanism to self-direct to target cells may
utilize adhesins or other surface-associated virulence factors present on
the OMV surface for transport to an appropriate destination. For example,
Actinobacillus actinomycetemcomitans leukotoxin or other unknown
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on bacterial membrane surfaces and interacts with the host cell surface
receptor β-2 integrin [24,25,27,28]. However, the association of
A. actinomycetemcomitans OMVs with the host cytoplasmic membrane
may occur independently of leukotoxin [25]. A. actinomycetemcomitans
vesicles are enriched not only in leukotoxin, but also in an OmpA homo-
logue, an OM lipoprotein component of an ABC transporter, as well as a
minor lipid species not detectable in the OM, and these factors may be
critical in directing OMVs to designated host cells [24]. In E. coli K1,
OmpA interacts with surface receptor Ecgp on brain microvascular endo-
thelial cells to mediate invasion [29,30]. It is possible that OmpA in
A. actinomycetemcomitans OMVs plays a similar role to mediate OMV
invasion.
In regard to cargo, OMV-mediated secretion uniquely enables export
of membrane-embedded proteins, membrane-associated proteins,
and other proteins which lack canonical secretion signal sequences.
Acinetobacter baumannii utilizes OMVs for secretion of AbOmpA, a
porin which allows for the passage of small solutes across the OM
[22]. This protein is abundant in culture supernatants and functions as
a virulence factor by directly contributing to host cell death. Proteomic
analysis of A. baumanniiOMVs reveals the presence of several other vir-
ulence factors besides AbOmpA, including active AmpC β-lactamase, a
putative hemolysin, and a Resistance-Nodulation-Cell Division (RND)
superfamily transporter (which catalyzes substrate efﬂux via an H+
antiportmechanism) [21]. In the absence of OMV formation,membrane
proteins like OmpAmust rely on bacterial-host cell contact for delivery.
Vesicles, however, may adeptly accomplish interactions with target
host cells, reaching even those cells residing in deep tissue often inac-
cessible to colonizing bacteria [5].
Additional advantages to packaging cargo into OMVs are that cargo
molecules may reach their destination in a concentrated manner
and/or simultaneouslywith other bacterial factors. P. aeruginosa vesicles
concurrently deliver multiple virulence factors, including β-lactamase,
Cif, hemolytic phospholipase, and alkaline phosphatase, to host cells in
their fully-folded and enzymatically active forms [23]. The delivery of
multiple virulence factors in a single concentrated bolus may allow
pathogens to impact host cells in a more complex, nuanced manner.
Furthermore, the speciﬁc environment offered by a membranous
compartment may allow for the establishment of a more potent or bio-
logically active enzyme. A. actinomycetemcomitans utilizes OMVs for ex-
port of a Type-I secreted RTX family-member, leukotoxin [24,25]. Once
inside human polymorphonuclear leukocytes and monocytes, toxin ac-
tivity induces cell lysis. Leukotoxin is not only an enriched component
of OMVs, it is also more potent when associated with vesicles than
with the OM [24].
Similarly, OMVs could facilitate the formation of higher-order com-
plexes from periplasmic or OM precursors. The pore-forming cytotoxin
ClyA exempliﬁes this advantage as its oligomeric OMV-associated form
exhibits higher cytotoxic activity than its monomeric periplasmic form
[26].
3. Proteins which utilize the OMV pathway
Bacteria export an assortment of proteins via OMVs. Functionally,
many vesicle-associated proteins are virulence factors, playing diverse
roles in invasion, adherence, antibiotic resistance, damage to host cells,
modulation of the host immune response, bioﬁlm formation, and promo-
tion of virulence. Other vesicle-associated proteins may perform roles in
interspecies cooperation and intercellular communication. For concision,
only bacterial products which have been functionally analyzed in associ-
ation with OMVs will be discussed (see Table 1 for a comprehensive list).
3.1. Invasion
Proteinswhich enhance the invasive abilities of bacteria may associ-
ate with OMVs to increase the invasive abilities of cells or may simplypromote more efﬁcient OMV internalization. Vesicles containing Ail, a
protein known to confer an invasive phenotype to laboratory E. coli
strains, exhibit 10-fold higher association with host cells than vesicles
without Ail [13,31]. In Shigella ﬂexneri, host uptake of vesicles is predict-
ed to be catalyzed by OM-localized invasins IpaB, C, and D [32].
3.2. Adherence
Components present in Actinobacillus vesicles enhance the ability of
Actinobacillus cells to adhere to oral KB epithelial cells [33]. Exactly how
OMV-localized material could inﬂuence the adherence of parent bacte-
ria is unknown. Potentially, the OMVs could bind epithelial cells and
bridge the interaction between bacterial and mammalian cell. Alterna-
tively, internalized OMVs could initiate changes in epithelial cell surface
receptor expression to enhance the ability of bacterial cell binding.
However, not all OMV-based adhesins positively impact bacterial
adherence. For instance, the OM proteins OspA and OspB bind bacterial
cell receptors on human umbilical vein epithelial, dendritic, and epithe-
lial cells. As these proteins are present on the surface of both OM and
vesicles, the vesicles of B. burgforferi compete for host cell binding
with bacterial cells [34].
3.3. Antibiotic resistance
For most Gram-negative bacteria, β-lactamase activity plays a key
role in raising the intrinsic level of resistance to penicillins and cephalo-
sporins [35]. P. aeruginosa packages β-lactamase into the lumen of
vesicles as a means of promoting resistance to β-lactam antibiotics [36].
Interestingly, the resistance gained from this type of OMV export could
be considered a community good, as extracellular β-lactamase beneﬁts
the entire bacterial population and not just the cells which produce the
resource. Additional components present in P. aeruginosa vesicles which
are able to kill other species [37] may serve to reduce instances of social
‘cheating,’ or use of the public good without equal contribution.
3.4. Damage to host cells
Enterohemorrhagic E. coli O157:H7 and Shigella dysenteriae both
package active Shiga toxin, Stx1 and Stx2, into OMVs [38,39]. Shiga
toxin is an AB5 family toxin with RNA-N-glycosidase activity which
works to inhibit eukaryotic protein synthesis [40]. Shiga toxin appears
to localize to both the OMV lumen and surface, as suggested by its
partial protease sensitivity and partial protease protection [19,38,39].
The OMVs of enterotoxigenic E. coli (ETEC) contain a substantial
portion of physiologically active heat-labile toxin (LT) [41]. A member
of the AB5 toxin family, LT uses the GM1 ganglioside binding capacity
of its B subunit to enter intestinal epithelial cells before the enzymatic
A subunit inactivates adenlyate cyclase, leading to increased cAMP levels
and eventual chloride efﬂux. Vibrio cholerae has also been reported to
secrete a portion of the highly related cholera toxin (CT) via OMVs
[42]. Like LT, CT also seems to mediate host cell internalization of the
pathogen-derived vesicles [13,42].
Campylobacter jejuni exports biologically active cytolethal distending
toxin (CDT) in association with vesicles [43]. CDT is a genotoxin respon-
sible for eukaryotic cell cycle arrest at the G2/M stage. Unlike most other
Gram-negative pathogens, the C. jejuni genome gives no evidence of
identiﬁable secretion systems for delivery of virulence factors into host
cells [44]. Accordingly, export of CDT via OMVs may be the major mech-
anism for coordinated release of the tripartite toxin.
3.5. Modulation of host immune response
Vesicle-associated proteins possess the capability to enact either pro-
or anti-inﬂammatory effects on host immune systems. Porphyromonas
gingivalis preferentially packages its major virulence factors, a group
of proteases named gingipains, into OMVs [45]. Gingipains degrade
Table 1
Comparison of OMV-associated proteins: Characteristics, alternative secretion mechanisms, and degree of OMV-association.
OMV-associated proteins Complex Protein type1/secretion
pathway2
Enrichment/Surface
exposure3
Number of exported forms4
(% OMV-associated)
References
β-lactamase 2 [36]
Leukotoxin (Ltx) A. actinomycetemcomitans S/Type I E/+ [22]
C. jejuni S/Type I E/+ 2 [73]
Shiga toxins (Stx, Stx1, Stx2) AB5 S/Type III 2 [37,38]
Heat-labile enterotoxin (LT) AB5 S/Type II E/+ 2 (95%) [40]
Cholera toxin (CT) AB5 S/Type II 2 [41]
Cytolethal distending toxin (CDT) A. actinomycetemcomitans CdtABC S + OMLP E/+ 2 (N95%) [42,73]
C. jejuni, E. coli CdtABC S + OMLP E/+ 2 [43,45,63,67]
Gingipains (RgpA, RgpB, Kgp) S + OM + 2 [44,80–82]
Vacuolating toxin (VacA) S + OM/Type V + 2 (25%) [69]
α-Hemolysin (HlyC) S/Type I E 2 (2–66%) [67]
Cytotoxin ClyA multimer S + OM E [30,53]
RTX (repeat-in-toxin) toxin S + OM/Type I E/+ 2 [76]
Cytotoxicity-associated immunodominant antigen (CagA) S/Type IV N/+ 2 [59]
Heme-utilization protein (HmuY) OMLP [48]
PhoP-activated gene C (PagC) OMP E 1 [54]
PhoP-activated gene J, K1, K2 (PagJ, PagK1, PagK2) S 1 [52]
Surface protein A1,A2 (UspA1, UspA2) oligomer OMP 1 [55]
CFTR inhibitory factor (Cif) S 2 [77,78]
Invasins (IpaB, IpaC, IpaD) OMP 1 [32]
Outer surface protein A, B (OspA, OspB) OMLP 1 [34]
Serralysin S/Type I E 2 [61]
High temperature requirement A protein (HtrA) oligomer S E/+ 2 [60]
Outer membrane porin A (OmpA) OMP 1 [22]
Adhesins (BabA, SabA) OMP X/+ 1 [60]
Aminopeptidase E/+ [11,79]
1 S: soluble protein; OMLP: outer membrane lipoprotein; OM: OM-association; and OMP: outer membrane protein.
2 Secretion system (Types I–V) used by the protein to traverse the bacterial envelope is indicated.
3 E: enriched as OMV cargo; N: neutral, neither enriched nor excluded as OMV cargo; X: excluded from OMV cargo; and +: Surface-exposed on OMVs.
4 1: OMV-associated form only; and 2: OMV-associated and OMV-independent forms.
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sponse. In contrast, C. jejuni OMVs work to provoke immune response.
OMV-mediated export of sixteen immunogenic N-linked glycoproteins
delivers proteins normally localized to the C. jejuni periplasm to host
cells [44].
Soluble ETEC LT elicits ultimately similar cytokine responses as OMV-
associated LT but through different activation pathways [46]. However,
comparison between the two export forms shows kinetic differences in
CREB activation, possibly due to the manner in which the different pre-
sentations of the toxin are trafﬁcked in the cell. In contrast, macrophage
cells sense both lipid and protein components of P. aeruginosa OMVs to
produce unique, strain-speciﬁc cytokine responses [47].
3.6. Bioﬁlm formation
P. gingivalis OMVs contain the surface-exposed heme-utilization
protein (HmuY), a putative heme-binding lipoprotein associated with
the OM [48]. HmuY aids in bioﬁlm formation and cell survival during
periods of starvation characteristic of plaque conditions [48].
3.7. Promotion of virulence
OMV production levels increase during conditions that stress the
bacterial envelope, such as host conditions during infection [49–51]. In
Salmonella typhimurium, the two-component system PhoP/Q directly
and indirectly regulates changes in LPS structure and expression of
virulence-related proteins necessary for the bacteria to transition from
an external environment to the host environment. A set of PhoP/
Q-activated genes, including pagC, pagK1/K2, and pagJ, encode proteins
which are associatedwithOMVs [52,53]. Although the function for PagC
is currently unknown, a PagC-deﬁcient strain displays decreased resis-
tance to complement-mediated killing [54]. PagK and PagJ play un-
known roles in virulence but as both proteins are only 39 amino acids
long, it is unlikely that they possess enzymatic activity [52].3.8. Interspecies cooperation
Moraxella catarrhalis OMVs export proteins that bind and inactivate
the complement protein C3. This secretion, acting as a sort of ‘community
good’, beneﬁtsM. catarrhalis and a co-inhabitant, Haemophilus inﬂuenza,
by promoting survival [55].
4. Mechanistic models for protein export via OMVs
Electron microscopy data suggests a simplistic vesicle formation
model: the OM blebs outwards and pinches off, encapsulating lumenal
content derived from the periplasm. Yet the composition of the OMV
membrane often differs from the cell OM; likewise, the OMV lumen
differs from the cell periplasm, suggesting a speciﬁc and/or selective
mechanism for OMV cargo inclusion.
Preferential packaging of speciﬁc OM lipid and protein components
into vesicles may originate during the cell envelope biogenesis process-
es. Theoretically, compositionally distinct microdomains could result
from the insertion of new membrane material by LPS and OM protein
biogenesis mechanisms [56]. Addition of new membrane material is be-
lieved to occur in distinct patches which subsequently remain relatively
stable due to the unique nature of the outer leaﬂet of the OM. Speciﬁcally,
the outer bilayer LPSmolecules andmanyOMPs are not observed to sub-
stantially diffuse (except by cell growth) [56]. Thus, OM microdomains
formed during envelope biogenesis could possess compositional differ-
ences rendering certain areas more or less prone to form OMVs.
Sequestered into domains, particular LPS and OMP compositions
(both dependent on environmental conditions) could function as
‘signposts’ for sites of vesicle initiation (green symbols, Fig. 1A). The
‘signpost’ properties may pertain to physical membrane attributes such
as distinct curvature, ﬂuidity, charge, and/or afﬁnity. Appropriate inner
leaﬂet composition could organize to complement these features, as
phospholipids and lipoproteins within the inner leaﬂet likely experience
greater freedom to diffuse. Potentially, interleaﬂet couplingwith LPS acyl
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can could inﬂuence this process. Ultimately, the establishment of these
OMV formation-competent domains may trigger lumenal cargo enrich-
ment, detachment from the underlying peptidoglycan, and recruitment
of any vesicle-formation machinery.
In the following section, multiple models are proposed which at-
tempt to explain how the enrichment and exclusion of proteins and
lipids occurs and ultimately results in OMV formation (Fig. 1). More
mechanistic details of how envelope architecture impacts OMV forma-
tion have been comprehensively discussed in other reviews [57,58].
4.1. OMV cargo enrichment or exclusion
Notably, the mechanism by which certain protein cargo is enriched
or excluded from vesicles remains elusive. Enrichment is achievedFig. 1.Models of envelope organization prior to outer membrane vesicle (OMV) budding that
lipopolysaccharide (LPS) are likely found in pre-existing microdomains in the outer membra
one area may be inherently more prone to budding. This organization can lead to the enrichm
lead to enrichment of other envelope factors (B–F). Envelope features for parts B–F are as indicat
envelope components coded by shape (indicated in the side legends) and color (OMV excluded
symbols). B. The localization of periplasmic proteins (PP proteins) to the external face of the
may enhance incorporation into OMVs. C. Recruitment factors, potentially OM lipoproteins (O
localization to future budding sites. D. Exclusion factors, such as OMPs or OMLPs excluded from
corporation into OMVs. E. Protein secretion apparatusesmay exist near potential sites of buddin
these secreted proteins may cluster on the external surface. These areas of high local protein c
positive curvature. F. A combination of all of the previously-described mechanisms most likel
(LPP)—peptidoglycan (PG) crosslinks are notably absent from potential OMV bud sites, eitherwhen the concentration of a certain protein cargo, normalized to
major OMP concentration, lipid concentration, or total protein, is higher
relative to that protein's concentration in the whole cell or a particular
cellular compartment. Negative enrichment, where relative concentra-
tion of a protein is higher in the cell than in OMVs will be referred to
as exclusion.
Evidence suggests that the cellular localization of a protein greatly
affects its potential for inclusion into OMVs. For instance, inHelicobacter
pylori the majority of OM proteins (77%) can be found in OMVs [59].
Even so, some highly abundant OM proteins are actively excluded
from OMV export. For instance, the Serratia marcescens OMPs TolC,
LptD, maltoporin, and YaeT are present in the OM yet are absent or un-
detectable in OMVs [60]. This type of exclusion observed byOMVprote-
omic studies is a theme throughout a wide range of Gram-negative
species. Excluded OMPs, lacking the ability to diffuse, could act tocould lead to cargo enrichment and exclusion. A. Outer membrane proteins (OMPs) and
ne, resulting directly from the membrane biogenesis processes. The content clustered in
ent of particular OMPs into OMVs. Subsequent partitioning of envelope components can
ed inpart A: outermembrane (OM); periplasm (PP); innermembrane (IM); and individual
cargo: red symbols; enriched cargo: green symbols; neither enriched/excluded cargo: blue
inner membrane (IM) may lead to exclusion from OMVs while localization to the OM
MLPs) or OMPs (green symbols), may bind to or interact with OMV cargo to enhance its
OMVs (red symbols) may interact with or bind to PP proteins in order to hinder their in-
g. If their secretion substrate binds an OM component or OM-associated component, then
oncentration could cause crowding and thereby provide the energy for establishment of
y is at work to promote budding and OMV formation. In each of the models, lipoprotein
by an exclusion mechanism or by conformational changes to the LPP.
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recruit other excludedmembrane andperiplasmic factors (red periplas-
mic proteins, OMLPs, and LPS, Fig. 1B–F).
In an intriguing juxtaposition, the S. marcescens OMP MipA is found
exclusively in OMVs and is undetectable in OM [60]. In the case of pro-
teins like MipA, absence from the OM suggests a mechanism whereby
speciﬁc newly synthesized proteins are targeted for incorporation into
the OM before immediate export via OMVs (green OMP symbols,
Fig. 1A). In this scenario, the localization of active Bamcomplexes, protein
complexes consisting of a single OMP and four OM lipoproteins (OMLPs)
which catalyze the assembly of OMPs by an unknownmechanism,would
predict locations of future buddingOMVs [61]. Bulkﬂowof envelope con-
tent into these sites by random diffusion events would lead to neutral
(neither enriched nor excluded) incorporation into OMVs.
A protein localized to the periplasmic space but tightly associated
to the IM (red periplasmic proteins, Fig. 1B) will likely experience
lesser incorporation into OMVs than an OM-associated protein (green
periplasmic proteins, Fig. 1B). For instance, removal of 11C-terminal
residues fromClyA abolishes its OMV-association as ClyA becomes asso-
ciatedwith the IM [62]. In contrast, periplasmic proteins associatedwith
the inner leaﬂet of the OM may display higher rates of incorporation
into OMV. Localization of this sort plays a key role in the export of
CDT. In A. actinomycetemcomitans and C. jejuni, the three subunits of
CDT (CdtA, B, and C) are translocated to the periplasm. The “lipobox”
contained within the N-terminal signal sequence of CdtA targets this
subunit for lipid modiﬁcation. This modiﬁcation targets CdtA to the
OM as a lipoprotein [63]. With CdtA acting as a spatial anchor, the full
CDT complex forms in association with the OM prior to additional
processing and eventual export via OMVs. It is possible that lipid-
modiﬁcations and other interactions with OMLPs play a signiﬁcant,
but as of yet unidentiﬁed, role in the mechanism of cargo selectivity
and vesicle formation. Study of OMLPs may reveal novel ties to OMV
formation or production. Approximately 100 different OMLPs exist in
the E. coli OM, yet very few have known functions [35].
OMV secretion or cellular retention decisions for envelope proteins
may be governed by tags (Fig. 1C, D). In S. typhimurium, the N-terminal
signal sequence from PagK is necessary for its periplasmic localization
but is not sufﬁcient for incorporation into OMVs [52]. However, the cyto-
lysin ClyA of E. coli accumulates in the periplasmic space prior to surface
exposure andOMV-exportwithout the cleavage of anyN-terminal signal
sequence [62]. No common primary structure has been identiﬁed as a
OMV sorting or exclusion signal, however it is possible that a more
complex tag, utilizing properties from a protein's three-dimensional
structure, could direct speciﬁc cargo into vesicles.
Cargo proteins could also directly promote their own export through
localized, physical enhancement of OMV production (Fig. 1E). In
S. dysenteriae, treatment with mitomycin C induces higher Shiga toxin
expression. The increased production of Shiga toxin, a known OMV
cargo protein, leads to increased OMV production, toxicity, and size
[38]. Directed localization of secretion apparatuses and/or Bam com-
plexes could promote high local concentrations of cargo protein within
a region of periplasmic space, within the OM, or attached to the cell sur-
face. A high local periplasmic or OM concentration of a cargo protein
could accelerate OM budding. In the case of surface-associated proteins
destined for OMV export, the high concentration of proteins bound to
themembranemay impart a protein-protein crowding effect that accel-
erates formation of OM curvature appropriate for OMV formation
(green external symbols, Fig. 1E).
Alternatively, sites of budding vesicles may contain protein and/or
lipid recruitment factors which lead to the accumulation of appropriate
OMV cargo. In P. gingivalis, mutations which alter LPS structure disrupt
normal protein sorting into OMVs [44]. In P. aeruginosa, two classes
of LPS, one negatively-charged and one neutral, exist in the OM, yet pri-
marily negatively-charged LPS is found in vesicles [11]. This negatively-
charged LPS is required for the formation of peroxide stress-induced
OMVs [64].In most cases, the mechanistic cause for differential degrees of
enrichment or exclusion for various protein cargo in OMVs is unclear,
and a combination of factors is likely important in promoting envelope
distension and OMV formation (Fig. 1F).
4.2. OMV-associated versus OMV-independent export
For some OMV-associated proteins, extracellular release is only pos-
sible as OMV cargo. Most of these proteins either are not substrates for
other secretion systems or are embedded in theOM. Alternatively, some
proteinswhich utilize other secretion systems bind LPSwith such a high
afﬁnity that the vast majority of extracellular protein observed is in an
OMV-associated state. Such is the case for the heat labile enterotoxin
(LT),with the vastmajority (95%) of LT activity in ETEC culture superna-
tant detected in the OMV fraction [40]. The ability of LT to bind LPS
allows it to remain associatedwith the bacterial OM. Accordingly, extra-
cellular LT is found both on the surface and interior of OMVs. The toxin's
ability to bind LPS as well as intestinal epithelial cell receptor GM1
ganglioside allows it to target LT-laden OMVs to host cells and initiate
internalization [13].
The strength of a certain protein's association with OMVs may be
related to the afﬁnity of the protein for LPS. Many gingipains and RTX
toxins (including leukotoxins and hemolysins) also bind or form high-
molecular weight complexes with LPS [65,66]. However, not all of
these proteins are found as highly-associated with OMVs as LT. Instead,
both OMV-associated and OMV-independent forms coexist extracellu-
larly. An in-depth study of the association of α-hemolysin with vesicles
from different strains of E. coli reveals an important relationship be-
tween LPS structure and toxin enrichment. Extraintestinal E. coli exports
α-hemolysin (HlyC), a fatty acid acyltransferase and RTX toxin family
member, to the extracellular space through a contiguous protein trans-
membrane channel. Despite being a known Type I secretion substrate, a
portion of extracellular HlyC is vesicle-associated. Four extraintestinal
E. coli isolates (likely R1 core type) display from 1.7% to 31.4% OMV-
associated HlyC in culture supernatants. Two E. coli K-12 derivatives
(K-12 core type) expressing HlyC show 11% and 17% of toxin as OMV-
associated, while in a previously-identiﬁed high OMV-producing mu-
tant of MC1061 (galE15 galU galK16, conferring a truncated “rough”
LPS core), 66% of the α-hemolysin is vesicle-associated. The differences
in LPS structure between these strains may inﬂuence the association of
α-hemolysin with OMVs and hint at a greater, but as of yet undiscov-
ered, role for OM lipids and lipopolysaccharide in OMV formation [67].
However, both OMV-associated export and OMV-independent
export also occur for many OMV-associated proteins which are not
known to bind or associate with LPS. Functionally, multiple methods
of release for a single protein into the external milieu could enhance dif-
ferent aspects of protein activity. In the case of two virulence factors of
H. pylori, VacA and CagA, OMV-association affects function, targeting,
and likelihood of delivery with other proteins. In highly virulent
H. pylori strains, the oncoprotein CagA and vacuolating toxin VacA are
involved in a functional relationship with one another thought to ﬁne-
tune the bacterial-host interaction. Both VacA and CagA are OMV-
associated and found on the surface of vesicles [59,68–70]. The presence
of VacA on H. pylori OMVs increases the rate of vesicle association with
host cells, as VacA is known to bind sphingomyelin, glycosphingolipids,
GPI-ancohored proteins, and receptor-like protein tyrosinephosphatase
β [71]. However, VacA is not found exclusively associated with vesicles
in culture supernatants. In two strains of H. pylori, only 25% of extracel-
lular VacA is OMV-associated [69]. Likely the presence or absence of
CagA in VacA-containing vesicles adds further complexity to the inter-
action of H. pylori with the host. Additionally, the OMV-associated
toxin displays poor vacuolating activity, indicating that the two export
methods of VacA, OMV-associated andOMV-independent,may play dif-
ferent pathobiological roles. This difference between OMV-associated
and OMV-independent VacA may arise in part due to the necessity for
urease, an enzyme secreted independently of OMVs by H. pylori, to
1617K.E. Bonnington, M.J. Kuehn / Biochimica et Biophysica Acta 1843 (2014) 1612–1619induce VacA toxicity [70]. Internalized VacA remains stable in eukaryotic
cells and its toxicity may be induced days post-internalization [72].
4.3. OMV subpopulations
As vesicles serve many diverse functions for bacteria, a population
of OMVs is likely varied in composition and size to more optimally
accomplish a smaller number of these roles.
In A. actinomycetemcomitans, active CDT (as well as the previously-
discussed leukotoxin) associates tightly with OMVs [73]. After density-
gradient centrifugation, analysis of fractions for CdtB, LtxA, and OmpA
reveals potential vesicle subpopulations. Higher density vesicles contain
CDT while the vesicles from lower density fractions contain LtxA.
Intermediate fractions display the presence of both CDT and LtxA,
representing either a third population containing both toxins or an
overlap between two content-disparate populations in size-proﬁles
and lipid-to-protein ratios.
In H. pylori OMVs, analysis of density-gradient centrifugation frac-
tions reveals an interesting relationship between OMV subpopulations
and cargo enrichment. VacA, known to be enriched in vesicles, is
present in all fractions in equivalent concentrations from fractions
5–11. CagA, which is neither enriched nor excluded from vesicles
(by protein content) in comparison with its concentration in the OM,
can only be observed in the higher density fractions (6–11) and its
concentration appears to increase with increasing vesicle density. Two
moderately-excluded adhesins, BabA and SabA, display similar proﬁles
in the gradient, being present throughout fractions 3–11 with peaks in
concentration around fraction 7 [59]. As both VacA and CagA also dis-
play adhesive properties, the lower concentration of BabA and SabA in
the higher density vesicles which contain the most VacA and CagA
may indicate that different populations of OMVs could be targeted to
different host cells and contain ﬁnely-tuned ratios of virulence factors
in order to play specialized roles in pathogenicity.
Further analysis of OMVs may be necessary in other Gram-negative
species to ascertain the existence, relationshipwith protein enrichment,
and function of multiple vesicle subpopulations.
4.4. Timing of OMV production
Proteomic analyses andmany other studies have yet to fully account
for the effect of themany cellular and environmental factors which feed
into the complex process of OMV formation and regulation on sample
preparation. Vesicles originate from a dynamic cell envelopewith struc-
ture and composition constantly changing in response to cellular and
environmental signals. As such, OMV samples collected from cultures
grownovernight are besetwith several problemswhichmake it difﬁcult
to identify potential vesicle subpopulations and complicate the discov-
ery of a single conserved “vesicle formation machinery.”
Firstly, a culture grown overnight from initial lag phase to the even-
tual stasis in stationary phase will have undergone dramatic transitions
in both peptidoglycan structure and OM composition. The peptidogly-
can sacculus of exponentially growing and stationary-phase E. coli
cells differs in glycan length, crosslinking, and covalent attachment of
Lpp. Speciﬁcally, in stationary phase, glycan length decreases and both
crosslinking and covalent attachment of Lpp increase [74].
Furthermore, OM protein composition may not remain constant
during a cell's progression through growth phases. Fernando and
Kumar demonstrated the correlation of A. baumannii bacterial growth
phase with the varying expression levels of two OM porins [75]. Analy-
sis of expression of carO and oprD genes via qPCR revealed a maximum
for carO at higher optical densities whereas oprD expression peaked at
early exponential phase [75]. For V. cholerae, the RTX toxin is found in
both anOM-independent andOMV-associated form, the concentrations
of which are dependent on complex regulatory mechanisms [76]. RTX
toxin activity is inﬂuenced by the growth-phase-dependent regulation
of the Type I secretion system which secretes the toxin, by decreasedtoxin expression in stationary phase, and by increased protease
expression in stationary phase cells. Accordingly, while RTX toxin may
be found abundantly in OMV-independent form during exponential
growth, all remaining toxin is observed to be vesicle- or OM-
associated in stationary phase [76].
5. Perspectives
The determination of whether a speciﬁc protein utilizes the OMV
pathway for export in a substantialmanner is a complex issue. Proteomic
data generate insight on protein presence in a particular vesicle sample
but can be misleading, as these do not reveal abundance (unless the
analysis is painstakingly undertaken using a quantitative assay) and
thus fail to expose whether a component is actively partitioned into
vesicles.
However, determination of abundance and enrichment in compari-
son to other cellular compartments is only meaningful if the amount
of an exported protein necessary to elicit a functional consequence is
taken into consideration. Whether or not the OMV-associated protein
is active, potent, in complex with other requisite factors, or found in
OMV-independent forms should also be determined.
Additionally, if distinct subpopulations of vesicles are isolated and
analyzed, greater insight into OMV formation mechanisms could be
gained. Comparisons between functionally different vesicles subpopula-
tions of a single species could reveal differences in lipid composition, as
well as protein enrichment and exclusion. These features could then be
related to the state of the envelope under different growth or inducing
conditions to reveal how timing and environmental factors contribute
to OMV production and function.
Accordingly, an exhaustive study on a speciﬁc protein exported by
OMVs should address the following questions:
Number of export forms: Howmuch protein is present in an OMV-
independent form versus an OMV-associated state?
Enrichment/Exclusion: How much protein is present in OMVs in
comparison to a relevant cellular compartment (e.g. periplasm,
OM)?
Subpopulations: Is the exported protein only present in a subset of
the total OMV population? What other proteins are co-exported
within the overall population or subset?
Timing: Does protein expression correlate with export? Does OMV
production and cargo incorporation change during different growth
phases?
Activity: Is protein activity/potency variable in cell-associated, OMV-
associated, to OMV-independent forms? Does OMV-association
enahance protein complex formation?
Location: Is the protein present in the lumen and/or presented on
the surface of OMVs?
Future studies of protein secretion via bacterial OMVs will likely
beneﬁt from the continually advancing technology in microscopy. As
achievable optic resolution improves, along with the availability of
new, more visible compartment markers and molecular tags, studies
to determine protein location coincident with the dynamics of OM
biogenesis and the cell envelope will soon be feasible.
Discovery of the mechanisms involved in the selectivity protein ex-
port via OMVs may be species-speciﬁc or rely on structural similarities
unable to be identiﬁed by simple homology studies. Potential vesicula-
tion machinery must be able to integrate and respond to multiple
and diverse signals: OM homeostasis, growth stage, metabolic state,
pathogenicity requirements, communication needs, and environmental
conditions. Comparative studies of multiple species using multiple
conditions will be important to elucidate the process.
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